TY - JOUR
T1 - Design of experiments in the optimization of nanoparticle-based drug delivery systems
AU - Rampado, Riccardo
AU - Peer, Dan
N1 - Funding Information:
This review is dedicated to Prof. Kinam Park for his years of devotion to research and his high standards that he implemented as Editor in Chief in the Journal of Controlled Release. We would also like to thank Teva Pharmaceutical Industries Ltd. for sponsoring this work.
Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2023/6
Y1 - 2023/6
N2 - Design of experiment (DoE) is a powerful statistical technique used for variable screening and optimization. It is based on the simultaneous variation of multiple factors with the objective of finding the configuration of parameters that optimizes one or more outputs of interest, while using the minimal number of experimental runs required for testing, resulting very cost and time-efficient. Despite the high potential offered by this approach for innovation and process optimization, DoE is still only marginally applied in the field of nanomedicine and often its rationale application and analysis result is difficult to grasp by many. In this review, we discuss some of the latest applications of DoE in the formulation of nanovectors used for drug delivery across many different applications. First, we introduce general principles of DoE to the reader, which are indispensable to understand the works we report. Then, we give particular attention to the process variables, the specific designs, and the readouts used for process analysis and optimization for different classes of nanovectors. Finally, we try to delve into the current shortcomings of DoE application and possible future directions that could be employed to further improve the information that can be derived from this approach.
AB - Design of experiment (DoE) is a powerful statistical technique used for variable screening and optimization. It is based on the simultaneous variation of multiple factors with the objective of finding the configuration of parameters that optimizes one or more outputs of interest, while using the minimal number of experimental runs required for testing, resulting very cost and time-efficient. Despite the high potential offered by this approach for innovation and process optimization, DoE is still only marginally applied in the field of nanomedicine and often its rationale application and analysis result is difficult to grasp by many. In this review, we discuss some of the latest applications of DoE in the formulation of nanovectors used for drug delivery across many different applications. First, we introduce general principles of DoE to the reader, which are indispensable to understand the works we report. Then, we give particular attention to the process variables, the specific designs, and the readouts used for process analysis and optimization for different classes of nanovectors. Finally, we try to delve into the current shortcomings of DoE application and possible future directions that could be employed to further improve the information that can be derived from this approach.
KW - Design of Experiment
KW - Drug delivery
KW - Nanomedicine
KW - Nanoparticles
KW - Optimization
KW - Screening
KW - Nanoparticle Drug Delivery System
KW - Drug Delivery Systems
UR - http://www.scopus.com/inward/record.url?scp=85159117205&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159117205&partnerID=8YFLogxK
U2 - 10.1016/j.jconrel.2023.05.001
DO - 10.1016/j.jconrel.2023.05.001
M3 - Article
C2 - 37164240
AN - SCOPUS:85159117205
SN - 0168-3659
VL - 358
SP - 398
EP - 419
JO - Journal of Controlled Release
JF - Journal of Controlled Release
ER -